Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CRIPTO pseudogene 5 (CRIPTOP5) is a processed pseudogene in the human genome that shares sequence homology with the CRIPTO gene but does not produce a functional protein[3][4]. While some pseudogenes can be transcribed and participate in gene regulation or RNA interference processes such as acting as decoys for microRNAs or generating small interfering RNAs (siRNAs)[1][2], there are no specific studies linking CRIPTOP5 to these functions. It is not categorized as a receptor, enzyme, transporter, or a recognized therapeutic target. There is no evidence of CRIPTOP5 being involved in any disease or drug interactions, nor is it used as a biomarker. If CRIPTOP5 was referenced as a receptor or therapeutic target, this would be incorrect; its role is limited to being a non-coding genomic element that may have evolutionary or regulatory implications, like other pseudogenes[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CRIPTO pseudogene 5 (CRIPTOP5).